Chromatin immunoprecipitation (ChIP) is a technique that helps researchers understand the relationship between DNA and the proteins that impact gene regulation.
The collaboration is expected to combine Millipore’s expertise in antibodies, ChIP kits and reagents with Agilent’s expertise in microarrays and data analysis solutions.
Geoffrey Crouse, vice president of Millipore’s life science strategic business unit, said: “Our long history of leadership in the ChIP market coupled with Agilent’s leadership in DNA microarrays will enable us to help scientists push the frontiers of epigenetic research.
“We expect to help epigenetics researchers minimize the barriers of entry into chromatin state mapping, readily obtain reproducible genomic profiling data, and overcome the traditional challenges of ChIP assays.”